Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

More than 6 million women in the U.S. have used the brand name mifepristone, Mifeprex, since approval in 2000, the drug maker, Danco Laboratories, told CBS News.

Four Democrat-led states ask FDA to remove abortion pill restrictions The attorneys general of New York, California, Massachusetts and New Jersey asked the FDA to lift some requirements on ...

Clinical trials previously cited by the FDA for the brand Mifeprex in 2023 said fewer than 0.5% of women suffered those complications. “Our data shows that chemical abortion poses greater risks ...

The manufacturers, Danco (which makes and markets the name-brand abortion pill Mifeprex) and GenBioPro (which makes and markets the generic version, mifepristone), also insist that their trials ...

Is the abortion pill dangerous? No, health officials say. When used within the first 10 weeks, mifepristone and misoprostol safely terminated 99.6% of pregnancies with low rates of complications.

OB/Gyn > Abortion Three States Renew Effort to Reduce Access to Abortion Pill Mifepristone — Lawsuit aims to require three in-person doctor visits, bar drug's use after 7 weeks of pregnancy by ...

Danco Laboratories is planning to seek FDA approval for the use of abortion pill Mifeprex for the treatment of miscarriages, The Wall Street Journal reported Oct. 8. Advertisement By: Alexandra Murphy ...

The drugmaker responsible for bringing the controversial abortion pill to the U.S. is now pursuing a new use that could widen women’s access: treating miscarriages.

Since its approval in the U.S. in 2000, there have been 5 deaths associated with mifepristone for every 1 million people who used it, according to the FDA. That means the death rate is 0.0005%.

Abortion rights, gun laws and more Carol Tobias, president of National Right to Life, condemned the decision, saying it deprived women of essential information about the dangers of the abortion pill.

Mifepristone has been used more than 5 million times in the U.S. since its FDA approval in 2000. The Supreme Court will weigh a challenge to expanding its access.